JUVENILE ABSENCE EPILEPSY
Clinical trials for JUVENILE ABSENCE EPILEPSY explained in plain language.
Never miss a new study
Get alerted when new JUVENILE ABSENCE EPILEPSY trials appear
Sign up with your email to follow new studies for JUVENILE ABSENCE EPILEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could stop absence seizures without extra meds
Disease control CompletedThis study tests whether brivaracetam, taken as an oral solution, can stop absence seizures in people aged 2 to 25 with childhood or juvenile absence epilepsy. Participants receive either the drug or a placebo, and seizure freedom is checked using a 24-hour EEG after 14 days. The…
Matched conditions: JUVENILE ABSENCE EPILEPSY
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New epilepsy drug shows promise for kids in Long-Term trial
Disease control CompletedThis study looked at the long-term safety and tolerability of the drug brivaracetam in 84 children and young adults (ages 2 to 26) with childhood or juvenile absence epilepsy. Participants who had already been in a previous study were given brivaracetam and monitored for side eff…
Matched conditions: JUVENILE ABSENCE EPILEPSY
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC